Managing chikungunya arthritis using etanercept
dc.contributor.author | V, Haridas | en_US |
dc.contributor.author | K, Haridas | en_US |
dc.date.accessioned | 2020-10-16T08:09:05Z | |
dc.date.available | 2020-10-16T08:09:05Z | |
dc.date.issued | 2019-08 | |
dc.description.abstract | Chikungunya virus or Aedes-borne alpha virus causes infection through an acute viremic phase and can be complicatedwith a chronic arthritis phase. The present case highlights the benefits of using etanercept for managing chikungunyaarthritis, especially in scenarios where NSAIDS and steroids are contraindicated due to multiple comorbidities. | en_US |
dc.identifier.affiliations | Arthritis Super Speciality Center, Hubli, Karnataka, India | en_US |
dc.identifier.citation | V Haridas, K Haridas. Managing chikungunya arthritis using etanercept. Internet Journal of Rheumatology and Clinical Immunology. 2019 Aug; 7(1): 1-3 | en_US |
dc.identifier.issn | 2320-7221 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/208143 | |
dc.language | en | en_US |
dc.publisher | ChanRe Healthcare | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 7 | en_US |
dc.source.uri | https://dx.doi.org//10.15305/ijrci/v7i1/307 | en_US |
dc.subject | chronic arthritis | en_US |
dc.subject | etanercept | en_US |
dc.subject | chikungunya | en_US |
dc.title | Managing chikungunya arthritis using etanercept | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1